Through capital investments, collaborative partnerships & acquisitions, DaVita Venture Group seeks to transform care delivery to patients with kidney disease and related conditions around the globe.
All capital comes from DaVita. We typically invest at Series A and beyond with check sizes that range from $1m-10m. We often syndicate but take an active role in all of our investments through Board observerships or director roles. Our support for portfolio companies extends beyond the board room with clinical and value based care delivery expertise, as well as business development, hiring, and technical support.
Interested in working with DaVita Venture Group? Please reach out directly to our team via Linkedin.